Chemomab Therapeutics Ltd ADR (CMMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,768 | 8,824 | 14,135 | 17,575 | 23,242 |
| Receivables | N/A | N/A | N/A | N/A | 1,236 |
| TOTAL | $7,388 | $9,672 | $14,677 | $18,211 | $24,478 |
| Non-Current Assets | |||||
| PPE Net | 15 | 18 | 121 | 158 | 370 |
| Intangibles | 0 | 0 | 0 | 0 | 3,346 |
| Other Non-Current Assets | 286 | 326 | 385 | 1,386 | 2,663 |
| TOTAL | $301 | $344 | $506 | $1,544 | $6,379 |
| Total Assets | $7,689 | $10,016 | $15,183 | $19,755 | $30,857 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 482 | 974 | 602 | 875 | 4,675 |
| Accrued Expenses | 1,620 | 609 | 2,681 | 2,855 | 962 |
| Other current liabilities | N/A | N/A | N/A | N/A | 9,171 |
| TOTAL | $2,275 | $1,751 | $3,471 | $4,121 | $15,313 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 63 | 108 | 152 | 725 | 6,258 |
| TOTAL | $63 | $108 | $152 | $725 | $6,258 |
| Total Liabilities | $2,338 | $1,859 | $3,623 | $4,846 | $21,571 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 116 | 116 | 116 | N/A | N/A |
| Retained earnings | -114,896 | -112,447 | -108,966 | -105,431 | -112,322 |
| Other shareholders' equity | 872 | 872 | 872 | 872 | 5,483 |
| TOTAL | $5,351 | $8,157 | $11,560 | $14,909 | $9,286 |
| Total Liabilities And Equity | $7,689 | $10,016 | $15,183 | $19,755 | $30,857 |